Abrezekimab (VR 942), featuring CDP7766, is a humanized, high-affinity monoclonal antibody fragment with neutralizing properties against human interleukin-13 (IL-13). It specifically binds to IL-13, effectively preventing interaction with the IL-13R??1 receptor subunit. This antibody is primarily utilized in asthma research to investigate the role and therapeutic potential of IL-13 inhibition in disease pathogenesis and progression.
Abrezekimab (VR 942), featuring CDP7766, is a humanized, high-affinity monoclonal antibody fragment with neutralizing properties against human interleukin-13 (IL-13). It specifically binds to IL-13, effectively preventing interaction with the IL-13R??1 receptor subunit. This antibody is primarily utilized in asthma research to investigate the role and therapeutic potential of IL-13 inhibition in disease pathogenesis and progression.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
